Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
2
Posts
2
Users
0
Reactions
378
Views
Topic starter
15/09/2021 12:56 am
Trying to separate three different claims about thymosin alpha-1: that it is the right molecule, that it is the right dose, and that it does something useful.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Anyone got a paper worth reading on this rather than a write-up of a paper?
15/09/2021 1:57 am
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Same for me with thymosin alpha-1, unfortunately.